http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2017, Vol. 26 ›› Issue (5): 390-394.DOI: 10.5246/jcps.2017.05.042

• Drug administration and clinical pharmacy column • Previous Articles    

Framework and local experience of pharmaceutical reimbursement criteria policy (PRCP) in China

Jiaxuan Yu1, Mengyuan Que1, Shuai Wang1, Ting Yin1, Jianfeng Wang2, Song Yang3, Bin Jiang1*   

  1. 1. Department of Administrative and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China
    2. Fujian Office of Medical Security, Fuzhou 350000, China
    3. Guotai junan Securities Research Institute, Shanghai 200120, China
  • Received:2016-12-16 Revised:2017-03-15 Online:2017-05-26 Published:2017-04-10
  • Contact: Tel. +86-13601100121, E-mail: binjiang@bjmu.edu.cn
  • Supported by:
    China Medical Board (CMB) Fund (Grant No. 15-221).

Abstract:

In the present study, we compared local policies in Chongqing, Zhejiang, Anhui, Fujian and Sanming and summarized connotation and framework of PRCP. Moreover, we proposed that China should make PRCP at the provincial level, strengthen connection with other health care reform policies under tripartite system reform, such as equivalence evaluation of quality and efficacy of generics, and evaluate policy effects timely to improve the policy.

Key words: Pharmaceutical reimbursement criteria, Local experience, Policy framework

CLC Number: 

Supporting: